vs

Side-by-side financial comparison of JACK IN THE BOX INC (JACK) and Lantheus Holdings, Inc. (LNTH). Click either name above to swap in a different company.

Lantheus Holdings, Inc. is the larger business by last-quarter revenue ($406.8M vs $349.5M, roughly 1.2× JACK IN THE BOX INC). Lantheus Holdings, Inc. runs the higher net margin — 13.3% vs -0.7%, a 14.0% gap on every dollar of revenue. On growth, Lantheus Holdings, Inc. posted the faster year-over-year revenue change (4.0% vs -25.5%). Lantheus Holdings, Inc. produced more free cash flow last quarter ($81.4M vs $7.3M). Over the past eight quarters, Lantheus Holdings, Inc.'s revenue compounded faster (4.9% CAGR vs -18.6%).

Jack in the Box, Inc. is an American fast food restaurant chain founded on February 21, 1951, by Robert O. Peterson in San Diego, California, where it is headquartered. The chain has over 2,200 locations, primarily serving the West Coast of the United States. Restaurants are also found in large urban areas outside the West Coast, as well as two in Guam. The company also formerly operated the Qdoba Mexican Grill chain until Apollo Global Management bought the chain in December 2017.

Lantheus Holdings, Inc. is a global healthcare firm specializing in the development, manufacturing and commercialization of innovative diagnostic imaging agents and related solutions. Its offerings cover core medical segments including oncology, cardiology and urology, with primary markets across North America and other key global regions.

JACK vs LNTH — Head-to-Head

Bigger by revenue
LNTH
LNTH
1.2× larger
LNTH
$406.8M
$349.5M
JACK
Growing faster (revenue YoY)
LNTH
LNTH
+29.6% gap
LNTH
4.0%
-25.5%
JACK
Higher net margin
LNTH
LNTH
14.0% more per $
LNTH
13.3%
-0.7%
JACK
More free cash flow
LNTH
LNTH
$74.1M more FCF
LNTH
$81.4M
$7.3M
JACK
Faster 2-yr revenue CAGR
LNTH
LNTH
Annualised
LNTH
4.9%
-18.6%
JACK

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
JACK
JACK
LNTH
LNTH
Revenue
$349.5M
$406.8M
Net Profit
$-2.5M
$54.1M
Gross Margin
59.2%
Operating Margin
13.3%
19.0%
Net Margin
-0.7%
13.3%
Revenue YoY
-25.5%
4.0%
Net Profit YoY
-107.3%
558.8%
EPS (diluted)
$-0.13
$0.86

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JACK
JACK
LNTH
LNTH
Q1 26
$349.5M
Q4 25
$406.8M
Q3 25
$384.0M
Q2 25
$336.7M
$378.0M
Q1 25
$371.1M
$372.8M
Q4 24
$391.1M
Q3 24
$378.7M
Q2 24
$365.3M
$394.1M
Net Profit
JACK
JACK
LNTH
LNTH
Q1 26
$-2.5M
Q4 25
$54.1M
Q3 25
$27.8M
Q2 25
$-142.2M
$78.8M
Q1 25
$33.7M
$72.9M
Q4 24
$-11.8M
Q3 24
$131.1M
Q2 24
$25.0M
$62.1M
Gross Margin
JACK
JACK
LNTH
LNTH
Q1 26
Q4 25
59.2%
Q3 25
57.9%
Q2 25
63.8%
Q1 25
63.8%
Q4 24
63.5%
Q3 24
63.9%
Q2 24
64.9%
Operating Margin
JACK
JACK
LNTH
LNTH
Q1 26
13.3%
Q4 25
19.0%
Q3 25
11.4%
Q2 25
-46.7%
23.3%
Q1 25
19.0%
27.4%
Q4 24
29.1%
Q3 24
35.3%
Q2 24
14.8%
26.1%
Net Margin
JACK
JACK
LNTH
LNTH
Q1 26
-0.7%
Q4 25
13.3%
Q3 25
7.2%
Q2 25
-42.2%
20.8%
Q1 25
9.1%
19.6%
Q4 24
-3.0%
Q3 24
34.6%
Q2 24
6.8%
15.8%
EPS (diluted)
JACK
JACK
LNTH
LNTH
Q1 26
$-0.13
Q4 25
$0.86
Q3 25
$0.41
Q2 25
$-7.47
$1.12
Q1 25
$1.75
$1.02
Q4 24
$-0.18
Q3 24
$1.79
Q2 24
$1.26
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JACK
JACK
LNTH
LNTH
Cash + ST InvestmentsLiquidity on hand
$359.1M
Total DebtLower is stronger
$1.6B
$568.7M
Stockholders' EquityBook value
$-936.0M
$1.1B
Total Assets
$2.0B
$2.2B
Debt / EquityLower = less leverage
0.52×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JACK
JACK
LNTH
LNTH
Q1 26
Q4 25
$359.1M
Q3 25
$382.0M
Q2 25
$695.6M
Q1 25
$938.5M
Q4 24
$912.8M
Q3 24
$866.4M
Q2 24
$757.0M
Total Debt
JACK
JACK
LNTH
LNTH
Q1 26
$1.6B
Q4 25
$568.7M
Q3 25
$567.9M
Q2 25
$1.7B
$566.8M
Q1 25
$1.7B
$566.1M
Q4 24
$565.3M
Q3 24
$613.0K
Q2 24
$1.7B
$563.2M
Stockholders' Equity
JACK
JACK
LNTH
LNTH
Q1 26
$-936.0M
Q4 25
$1.1B
Q3 25
$1.1B
Q2 25
$-976.2M
$1.2B
Q1 25
$-827.1M
$1.2B
Q4 24
$1.1B
Q3 24
$1.2B
Q2 24
$-702.6M
$1.0B
Total Assets
JACK
JACK
LNTH
LNTH
Q1 26
$2.0B
Q4 25
$2.2B
Q3 25
$2.3B
Q2 25
$2.6B
$2.1B
Q1 25
$2.8B
$2.1B
Q4 24
$2.0B
Q3 24
$2.0B
Q2 24
$2.9B
$1.9B
Debt / Equity
JACK
JACK
LNTH
LNTH
Q1 26
Q4 25
0.52×
Q3 25
0.51×
Q2 25
0.49×
Q1 25
0.49×
Q4 24
0.52×
Q3 24
0.00×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JACK
JACK
LNTH
LNTH
Operating Cash FlowLast quarter
$30.5M
$90.2M
Free Cash FlowOCF − Capex
$7.3M
$81.4M
FCF MarginFCF / Revenue
2.1%
20.0%
Capex IntensityCapex / Revenue
6.6%
2.2%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters
$34.8M
$354.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JACK
JACK
LNTH
LNTH
Q1 26
$30.5M
Q4 25
$90.2M
Q3 25
$105.3M
Q2 25
$-36.8M
$87.1M
Q1 25
$105.7M
$107.6M
Q4 24
$157.7M
Q3 24
$175.1M
Q2 24
$16.7M
$84.7M
Free Cash Flow
JACK
JACK
LNTH
LNTH
Q1 26
$7.3M
Q4 25
$81.4M
Q3 25
$94.7M
Q2 25
$-63.2M
$79.1M
Q1 25
$84.4M
$98.8M
Q4 24
$141.4M
Q3 24
$159.3M
Q2 24
$6.4M
$73.5M
FCF Margin
JACK
JACK
LNTH
LNTH
Q1 26
2.1%
Q4 25
20.0%
Q3 25
24.7%
Q2 25
-18.8%
20.9%
Q1 25
22.7%
26.5%
Q4 24
36.1%
Q3 24
42.0%
Q2 24
1.8%
18.7%
Capex Intensity
JACK
JACK
LNTH
LNTH
Q1 26
6.6%
Q4 25
2.2%
Q3 25
2.8%
Q2 25
7.9%
2.1%
Q1 25
5.7%
2.3%
Q4 24
4.2%
Q3 24
4.2%
Q2 24
2.8%
2.8%
Cash Conversion
JACK
JACK
LNTH
LNTH
Q1 26
Q4 25
1.67×
Q3 25
3.79×
Q2 25
1.11×
Q1 25
3.14×
1.47×
Q4 24
Q3 24
1.34×
Q2 24
0.67×
1.36×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JACK
JACK

Restaurant Sales$131.9M38%
Franchise$97.4M28%
Royaltyand Other$58.9M17%
Advertising$56.6M16%
Technology Service$4.7M1%
Franchise Fees$1.7M0%

LNTH
LNTH

Radiopharmaceutical Oncology$240.2M59%
Definity$85.3M21%
Strategic Partnerships And Other$23.3M6%
Techne Lite$21.0M5%
Licenseand Royalty Revenues$17.4M4%
Other$13.6M3%
Other Precision Diagnostics$5.9M1%

Related Comparisons